[1] |
VENICK RS. Current review on the role of ileostomy following intestinal transplantation[J]. Curr Opin Organ Transplant, 2022, 27(2): 126-130. DOI: 10.1097/MOT.0000000000000966.
|
[2] |
MIZUSHIMA T, UDAGAWA E, HASEGAWA M, et al. Etiologies and treatments of chronic intestinal failure-short bowel syndrome (SBS) in Japanese adults: a real-world observational study[J]. Surg Today, 2022, DOI: 10.1007/s00595-022-02469-9[Epub ahead of print].
|
[3] |
MCCALLUM Z, DELANY C, GILLAM L. Crossing the line? ethics of parenteral nutrition in paediatric neurodisability complicated by intestinal failure[J]. Arch Dis Child, 2022, DOI: 10.1136/archdischild-2021-323500[Epub ahead of print].
|
[4] |
MEROLA J, SHAMIM A, WEINER J. Update on immunosuppressive strategies in intestinal transplantation[J]. Curr Opin Organ Transplant, 2022, 27(2): 119-125. DOI: 10.1097/MOT.0000000000000958.
|
[5] |
FORTUNATO AC, PINHEIRO RS, MATSUMOTO CS, et al. Techniques for closing the abdominal wall in intestinal and multivisceral transplantation: a systematic review[J]. Ann Transplant, 2022, 27: e934595. DOI: 10.12659/AOT.934595.
|
[6] |
LERUT JP, GONDOLESI GE. Immunosuppression in liver and intestinal transplantation[J]. Best Pract Res Clin Gastroenterol, 2021, 54/55: 101767. DOI: 10.1016/j.bpg.2021.101767.
|
[7] |
WICHMANN D, NADALIN S, SCHWEIZER U, et al. Evaluating the diagnostic value of zoom endoscopic surveillance compared to routine biopsy after intestinal transplantation[J]. Dig Liver Dis, 2022, 54(3): 385-390. DOI: 10.1016/j.dld.2021.12.019.
|
[8] |
DUCLAUX-LORAS R, BERTHILLER J, FERRONI A, et al. Clostridium difficile: a frequent infection in children after intestinal transplantation[J]. Transplantation, 2020, 104(1): 197-200. DOI: 10.1097/TP.0000000000002795.
|
[9] |
SUDAN DL, KAUFMAN S, HORSLEN S, et al. Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipients[J]. Transplant Proc, 2000, 32(6): 1199. DOI: 10.1016/s0041-1345(00)01182-9.
|
[10] |
李元新, 黎介寿, 李宁, 等. 人体小肠移植的内窥镜监测[J]. 中华器官移植杂志, 1997, 18(4): 229-230. DOI: 10.3760/cma.j.issn.0254-1785.1997.04.019.LI YX, LI JT, LI N, et al. Endoscopic observation of human small intestinal transplantation[J]. Chin J Organ Transplant, 1997, 18(4): 229-230. DOI: 10.3760/cma.j.issn.0254-1785.1997.04.019.
|
[11] |
郭晖. 小肠移植排斥反应病理学[M]//陈实. 移植免疫学. 武汉: 湖北科技出版社, 1998: 235-237.
|
[12] |
MOON JI, SCHIANO TD, IYER KR. Routine surveillance endoscopy and biopsy after isolated intestinal transplantation-revisiting the gold standard[J]. Clin Transplant, 2019, 33(10): e13684. DOI: 10.1111/ctr.13684.
|
[13] |
JELLY ET, KWUN J, SCHMITZ R, et al. Optical coherence tomography of small intestine allograft biopsies using a handheld surgical probe[J]. J Biomed Opt, 2021, 26(9): 096008. DOI: 10.1117/1.JBO.26.9.096008.
|
[14] |
CRISMALE JF, MAHMOUD D, MOON J, et al. The role of endoscopy in the small intestinal transplant recipient: a review[J]. Am J Transplant, 2021, 21(5): 1705-1712. DOI: 10.1111/ajt.16354.
|
[15] |
KÖNIGSRAINER A, LADURNER R, IANNETTI C, et al. The 'blind innsbruck ostomy', a cutaneous enterostomy for long-term histologic surveillance after small bowel transplantation[J]. Transpl Int, 2007, 20(10): 867-874. DOI: 10.1111/j.1432-2277.2007.00541.x.
|
[16] |
GULLEROGLU K, BASKIN E, OZDEMIR H, et al. Clinical impact of complement deposition findings on biopsies in acute rejection episodes of pediatric renal transplant patients[J]. Transpl Immunol, 2021, 69: 101466. DOI: 10.1016/j.trim.2021.101466.
|
[17] |
FUJINO T, KUMAI Y, YANG B, et al. Discordance between immunofluorescence and immunohistochemistry C4d staining and outcomes following heart transplantation[J]. Clin Transplant, 2021, 35(4): e14242. DOI: 10.1111/ctr.14242.
|
[18] |
ŁABUŚ A, MUCHA K, KULESZA A, et al. Costs of treatment of acute antibody-mediated rejection in kidney transplant recipients[J]. Transplant Proc, 2022, DOI: 10.1016/j.transproceed.2021.11.039[Epub ahead of print].
|
[19] |
LOUIS K, MACEDO C, LEFAUCHEUR C, et al. Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection[J]. Trends Mol Med, 2022, 28(3): 237-250. DOI: 10.1016/j.molmed.2022.01.002.
|
[20] |
WU GS, CRUZ RJ JR, CAI JC. Acute antibody-mediated rejection after intestinal transplantation[J]. World J Transplant, 2016, 6(4): 719-728. DOI: 10.5500/wjt.v6.i4.719.
|
[21] |
STOBUTZKI N, SCHLICKEISER S, STREITZ M, et al. Long-term signs of T cell and myeloid cell activation after intestinal transplantation with cellular rejections contributing to further increase of CD16+ cell subsets[J]. Front Immunol, 2019, 10: 866. DOI: 10.3389/fimmu.2019.00866.
|
[22] |
SPAGGIARI M, LICHVAR A, TZVETANOV I, et al. Temporary deceased donor splenic transplant prior to intestinal transplantation: a new strategy for desensitization?[J]. Transplant Proc, 2021, 53(8): 2602-2608. DOI: 10.1016/j.transproceed.2021.08.008.
|
[23] |
MATSUMOTO CS, ROSEN-BRONSON S. Donor-specific antibody and sensitized patients in intestinal transplantation[J]. Curr Opin Organ Transplant, 2021, 26(2): 245-249. DOI: 10.1097/MOT.0000000000000853.
|
[24] |
GAITONDE S, HASSAN M, MEHTA V, et al. Histopathology of human donor spleen utilized as a desensitization tool before intestinal transplantation[J]. Am J Clin Pathol, 2021, 155(5): 621-626. DOI: 10.1093/ajcp/aqaa175.
|
[25] |
CORREA-MARTÍNEZ CL, BECKER F, SCHWIERZECK V, et al. Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation[J]. Antimicrob Resist Infect Control, 2020, 9(1): 180. DOI: 10.1186/s13756-020-00845-z.
|
[26] |
ÅBERG F, SAVIKKO J, ANTTILA VJ, et al. Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report[J]. Clin Case Rep, 2018, 6(7): 1232-1235. DOI: 10.1002/ccr3.1493.
|
[27] |
STANLEY K, RANGANATHAN S, MAZARIEGOS G, et al. Donor mucosal immunocytes perpetuate refractory GVHD after intestinal transplantation without engrafting in recipient bone marrow: case report and review of the literature[J]. Pediatr Transplant, 2019, 23(2): e13350. DOI: 10.1111/petr.13350.
|
[28] |
GERLACH UA, MORLAND B, HOBIN D, et al. Atypical malignancies after intestinal transplantation in children: a European single-centre experience[J]. Pediatr Transplant, 2020, 24(3): e13697. DOI: 10.1111/petr.13697.
|
[29] |
KAUFMAN SS, HUSSAN E, KROEMER A, et al. Graft versus host disease after intestinal transplantation: a single-center experience[J]. Transplant Direct, 2021, 7(8): e731. DOI: 10.1097/TXD.0000000000001187.
|
[30] |
GANOZA A, MAZARIEGOS GV, KHANNA A. Current status of graft-versus-host disease after intestinal transplantation[J]. Curr Opin Organ Transplant, 2019, 24(2): 199-206. DOI: 10.1097/MOT.0000000000000624.
|
[31] |
OLTEAN M. Intestinal transplantation: an overview of the recent experimental studies[J]. Curr Opin Organ Transplant, 2021, 26(2): 240-244. DOI: 10.1097/MOT.0000000000000845.
|
[32] |
DEVINE K, RANGANATHAN S, MAZARIEGOS G, et al. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: single-center experience[J]. Pediatr Transplant, 2020, 24(5): e13723. DOI: 10.1111/petr.13723.
|
[33] |
CHIOU FK, BEATH SV, MORLAND B, et al. Comparison of clinical features and outcome of pediatric posttransplant lymphoproliferative disorder in recipients of small bowel allograft versus isolated liver transplantation[J]. Transplantation, 2020, 104(7): 1429-1436. DOI: 10.1097/TP.0000000000003004.
|
[34] |
ANDRES AM, RAMOS E, HERNANDEZ F. Current status of pediatric intestinal transplant in Europe[J]. Curr Opin Organ Transplant, 2020, 25(2): 183-188. DOI: 10.1097/MOT.0000000000000736.
|